Hidemasa Tanigaki

Operating Partner

Hidemasa is an Operating Partner with Catalys Pacific. He has an outstanding track record and has been a leader in the pharmaceutical sector for over the last 30 years. Hidemasa began his journey with Takeda Pharmaceutical Company in 1992 and held numerous key positions throughout his tenure with the company. After starting his career, he was later involved the successful launch of multiple products n the Marketing Department. From 2015, he was global lead in Boston for the oncology business strategy. Upon his return to Japan, he served as Sales Director for Specialty Pharma and the Head of Rare Hematology, before assuming the role of President and Representative Director of Nihon Pharmaceutical Co., Ltd. in 2021. He then led the Gastrointestinal Disease Business Unit at Takeda. Hidemasa joined Aculys in April 2024 as CEO.

“Think with clarity, welcome new perspectives with openness, execute with conviction, and pivot without hesitation. This discipline unlocks paths no one has yet imagined.”

IKIGAI

Clear thinking defines my direction. Openness expands the opportunities I can capture. Disciplined execution turns strategy into tangible outcomes. Fearless pivots enable continued relevance and future growth. Living these four principles in constant motion is the engine that propels my journey—and the value I strive to create.